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MinireviewDendritic Cells: Specialized
and Regulated Antigen
Processing Machines
cells are adept at endocytosis and express relatively low
levels of surface MHC class I and II products and costimu-
latory molecules (e.g., CD86). Abundant MHC class II mol-
ecules are synthesized, but they are mainly sequestered
intracellularly in late endocytic compartments (lyso-
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2 Laboratory of Cellular Physiology and Immunology somes; Figure 1, left). As in other MHC class II-express-
ing cells, the majority of new class II molecules are targetedThe Rockefeller University
New York, New York 10021 directly to endosomes and lysosomes following their di-
version from the secretory pathway upon exit from the
trans-Golgi network (Pierre et al., 1997). However, a vari-
It is easy to be fascinated by dendritic cells (DCs), not able fraction of MHC class II is likely to reach lysosomes
only because of their pivotal role in the immune response, following endocytosis from the plasma membrane, par-
but also because of the elegance with which they perform ticularly in monocyte-derived DCs (Cella et al., 1997).
their tasks. Although DCs comprise multiple subsets (Liu, Antigens can be avidly taken up by immature DCs and
2001 [this issue of Cell]), all are unusually effective at anti- targeted to MHC class II-positive lysosomes. However,
gen processing and presentation. DCs can take up a di- they are not efficiently utilized for the formation of MHC
verse array of antigens and present them to T cells as II-peptide complexes, but are retained for use as immu-
peptides bound to both MHC class I and II products. nogenic peptides days later (Inaba et al., 2000; Turley
Relative to other antigen presenting cells, DCs are adept et al., 2000). Immature cells do form SDS-stable class
at stimulating naı¨ve T cells. DCs also control the quality II dimers, but their presence does not correlate with the
of the T cell response, driving naı¨ve lymphocytes into production of immunogenic complexes (Pierre et al.,
distinct classes of effectors. These antigen-specific, adap- 1997). Thus, immature DCs in culture can take up antigen
tive responses are critical for resistance to infections and but do not present it efficiently to T cells. Most DCs in
tumors. Conversely, DCs can also generate regulatory T peripheral tissues in situ are of the immature phenotype,
cells that suppress activated T cells, a function of likely the prototype being Langerhans cells in the epidermis.
importance in autoimmunity and transplant rejection. After detecting microbial products or proinflammatory
In addition to their role in adaptive responses, DCs cytokines, immature DCs transform into mature DCs,
play a critical role in innate immunity. In some respects, cells with a reduced capacity for antigen uptake but
DCs are as active in responding to microbial challenge now with an exceptional capacity for T cell stimulation.
as DCs can produce copious amounts of cytokines in- This transition is accompanied by a dramatic cyto-
volved in host defense, such as IL-12 and both type I plasmic reorganization highlighted by a redistribution of
and II interferons. DCs also activate NK and NKT cells, MHC class II from intracellular compartments to the
innate lymphocytes that rapidly kill select targets and plasma membrane. Class II molecules appear to exit from
produce important cytokines. the lysosomes, then to reside transiently in nonlysosomal
Initiating immunity may be only half of the story, however. cytoplasmic structures (class II vesicles or CIIV), and fi-
It is becoming increasingly clear that DCs also capture nally to accumulate on the cell surface (Figure 1, right).
antigens against which immunity is normallyavoided. These In tandem, surface costimulatory molecules (CD80, CD86),
include environmental proteins chronically found in the re- MHC class I, and T cell adhesion molecules (e.g., CD48
spiratory and digestive tracts (Vermaelen et al., 2001), as and CD58) are all upregulated. The maturing DCs also
well as self antigens derived from tissues exhibiting consti- upregulate the capacity to generate functional peptide-
tutive cell turnover (Huang et al., 2000). Conceivably, the MHC II complexes from newly internalized antigen or from
capture of proteins in the steady state, i.e., in the absence antigen internalized prior to the maturation signal (Inaba
of microbial or other perturbations, allows DCs to control et al., 2000; Turley et al., 2000). The cells extend long
tolerance to self and “normal” environmental constituents. “dendritic” processes (actually, membrane folds) that may
How is it that DCs can mediate such diverse, almost increase opportunities for T cell capture and interaction.
contradictory functions in the immune response and do DCs also remodel their profile of chemokine receptors that
so with such efficiency? Here, we concentrate on newly facilitate homing to lymphoid organs.
appreciated specializations that enable DCs to capture Much of what is known concerning DC maturation has
and process antigens in a distinct manner relative to been learned from DC cultures, either cells differentiated
other antigen presenting cells. These qualitative and with GM-CSF and IL-4 from nongrowing human blood
quantitative distinctions are regulated by inflammatory monocytes or from proliferating bone marrow-derived
and microbial stimuli in a developmental process termed precursors (mouse, rat, or human). The current view has
“maturation.” In effect, maturation couples innate to immature DCs encountering antigen in the periphery
adaptive responses and is potentially pivotal in the self- and carrying it to lymphoid organs, maturing en route.
nonself distinction orchestrated by DCs. While valuable in general terms, this view is probably
Terminal Differentiation Determines Immunity too simple for describing the DC system in vivo. For
DCs in culture exist in two functionally and phenotypically example, DCs migrating from the periphery may not
distinct states, immature and mature (Figure 1). Immature always be the ones that present antigen in the lymph
nodes. Rather, migrating DCs may transfer their cap-
tured antigens to other DCs for presentation. The trans-3 Correspondence: ira.mellman@yale.edu
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bound ligands) must also be endocytosed. The internal-
ized volumes of fluid are high, possibly explaining the
expression of aquaporins 3 and 7 which provide for
water efflux (de Baey and Lanzavecchia, 2000).
Macropinocytosis and phagocytosis are related pro-
cesses, both depending on regulated actin assembly
and thus the activity of the Rho family GTPases Cdc42
and Rac (Garrett et al., 2000; West et al., 2000). Phagocy-
tosis is triggered by the attachment of extracellular parti-
cles to surface receptors, which in turn signal particle
uptake. From an evolutionary perspective, bacterial or
particle ingestion by phagocytosis is probably the most
physiologically relevant form of antigen uptake by DCs.
In fact, derivation of antigenic peptides from phagocy-
tosed antigens is particularly efficient (Inaba et al., 1998).
The downregulation of endocytosis begins soon after
the receipt of a maturation signal. Mechanistically, it mayFigure 1. Dendritic Cell Maturation Induces Multiple Alterations in
reflect a reduction in levels of active (GTP-bound) Cdc42,the Function and Intracellular Transport of MHC Class II Molecules
presumably via the regulation of a guanine nucleotide ex-
change factor (Garrett et al., 2000). Clathrin-coated vesicle
formation appears to continue, so mature DCs must not befer could occur either by phagocytosis of the antigen-
considered as being completely incapable of endocytosis.loaded DCs (Inaba et al., 1998) or by the release of
Some DC subsets may exhibit novel strategies forantigen-bearing vesicles (exosomes) derived from a
endocytosis. Epidermal Langerhans cells, for example,DC’s lysosomal compartment (Thery et al., 1999). An-
reside in an environment not characterized by abundantother oversimplification is the idea that all DCs within a
extracellular fluid, making it unlikely that they surveylymph node are mature. Most DCs within lymph node
their surroundings by macropinocytosis. An intriguingin situ may be able to form MHC-peptide complexes,
alternative is provided by Birbeck granules (BGs), cyto-but they are otherwise immature and may function to
plasmic membrane-bound tubules exhibiting distinct in-induce peripheral tolerance (see below).
ternal striations. BGs are enriched in a lectin, langerinSignals Leading to Dendritic Cell Maturation
(CD207), whose expression even in fibroblasts can in-DC maturation is typically triggered by products of mi-
duce granule formation (Valladeau et al., 2000). It re-crobial or viral pathogens, such as LPS, CpG DNA, or
mains to be established whether langerin, or analogousdsRNA. For many or all of these, one or more members
lectins, are physiologically important for antigen uptake.of the family of Toll-like receptors (TLRs) play a critical
Mechanisms for the Upregulation of Peptide-MHCrole (Kaisho and Akira, 2001). It remains unclear if bacte-
II Complexes During Maturation
rial products interact directly or indirectly with TLRs,
One of the hallmarks of DC maturation is a dramatic
and in some cases, endocytosis of the maturation stimu-
increase in surface MHC class II and costimulatory mole-
lus may precede TLR activation. The involvement of
cules. MHC class II products can increase some 5- to
TLRs in maturation provides an attractive mechanism 20-fold while CD86 increases up to 100-fold. The upreg-
by which DCs link innate to adaptive immunity. ulation of surface MHC class II largely reflects posttrans-
Proinflammatory cytokines, such as TNF and IL-1 lational events. There is only a slight increase in the
also trigger maturation, as does ligation of CD40, a TNF amount of MHC II mRNA following receipt of a matura-
receptor family member abundant on DCs. TLRs, IL-1R, tion signal; in mature DCs, MHC class II synthesis actu-
and TNF receptors each lead to NF-B activation, a hall- ally decreases. Instead, there are major changes in the
mark of mature DCs. DC maturation also can be initiated intracellular transport of MHC class II molecules.
by a variety of noninflammatory and pathogen-unrelated In immature cells, as mentioned above, new MHC
stimuli. In DC cultures, this is exemplified by the fact that class II accumulates in late endosomes and lysosomes
gentle disruption of cell-cell contacts induces maturation while in mature DCs, class II molecules accumulate at
(Pierre et al., 1997). We suspect that different stimuli are the cell surface (Cella et al., 1997; Pierre et al., 1997).
likely to trigger qualitatively different states of maturation, The reasons for this change undoubtedly reflect the
suggesting that either via TLRs or other receptors, DCs contributions of multiple factors, and may vary among
“decode” environmental signals, allowing for the develop- individual MHC class II haplotypes and DC populations.
ment of mature DCs capable of polarizing T cell responses One element of the mechanism, possibly unique to DCs,
or inducing tolerance. It is already known, for example, may involve the regulation of cathepsin S (cat S) activity
that certain maturational stimuli (e.g., LPS) will favor the by the specific antiprotease cystatin C (Pierre and Mell-
development of Th1 versus Th2 cells in vitro, in part due man, 1998). Cat S has a major role in the cleavage of
to the release of IL-12 by DCs that induce Th1 polarity. the MHC II-associated invariant (Ii) chain. The lumenal
Dendritic Cell Maturation and Endocytosis aspect of Ii chain occupies the peptide binding groove
Most immature DCs exhibit three types of endocytosis: of newly synthesized MHC II  dimers, while the cyto-
macropinocytosis, phagocytosis, and clathrin-mediated plasmic domain contains a lysosomal targeting signal.
endocytosis. In culture, the bulk of fluid uptake is In immature mouse DCs, levels of cystatin C appear
thought to reflect macropinocytic activity. Correspond- sufficient to attenuate cat S activity, slowing Ii chain
processing and favoring MHC II transport to lysosomes.ingly large amounts of plasma membrane (and receptor-
Minireview
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Antigen Presentation on MHC Class I:
Breaking Convention
Compared to MHC class II, relatively little effort has yet
been focused on MHC class I-restricted antigen presen-
tation in DCs. MHC class I does not accumulate in the
lysosomes of immature mouse DCs (although it may in
immature LCs), but it too is upregulated upon matura-
tion, possibly reaching the surface in part together with
class II molecules (Turley et al., 2000). Maturation may
drive the formation of “immunoproteasomes,” a combi-
natorial form of the proteasome that influences the pep-
tides destined to be presented on MHC class I. Most
Figure 2. Dendritic Cell Specializations that Control the Formation intriguingly, DCs are specialized to form MHC class I
of MHC-Peptide Complexes peptide complexes by what is called the “exogenous”
or “cross presenting” pathway.
Classically, the MHC I pathway provides for the pre-
After maturation, intracellular cystatin C decreases en- sentation of endogenous cellular antigens. For example,
hancing cat S activity and allowing a greater fraction of in virus-infected cells, viral proteins expressed in the
new  dimers to avoid lysosomes and reach the cell cytosol are subject to proteasomal proteolysis and the
surface. The downregulation of endocytosis must also resulting peptides translocated via TAP transporters
contribute to the enhanced residence of MHC class II on into the ER lumen for loading onto waiting MHC I mole-
the plasma membrane of mature DCs. Inhibiting Ii chain cules. This paradigm may provide some difficulty for
cleavage in mature DCs or cystatin C-negative cells using DCs, however. A priori, it seems unlikely that all viruses
cat S inhibitors or cystatin C transfection restores a lyso- can infect DCs. One alternative is that DCs encounter
infected cells in the periphery, phagocytosing the dyingsomal pathway. This strategy is used by at least one
cells via receptors specific for such forms of uptakeparasitic nematode which releases a cystatin C homolog
(e.g., V 5 integrins). Indeed, immature DCs take upto negatively regulate the MHC class II pathway and
dying cells avidly and then “cross-present” viral anti-possibly evade immune detection (Manoury et al., 2001).
gens from the infected cells to CD8 T cells (Albert etEven more interesting is the fate of MHC II that has
al., 1998). Several reports have shown that DCs alsoaccumulated in lysosomes prior to maturation. These
process tumor antigens from phagocytosed tumor cellsmolecules are somewhat more susceptible to degrada-
for presentation on MHC I (and MHC II).tion than those on the cell surface (Cella et al., 1997;
Soluble exogenous antigens also can be cross-pre-Pierre et al., 1997), but nevertheless survive 1–2 days.
sented from nonreplicating microbes and immune com-Using an antibody to a hen egg lysozyme (HEL) peptide-
plexes, the latter taken up via Fc receptors (RodriguezMHC II (I-Ak) complex, maturation has been found to
et al., 1999). Uptake of the same antigens by FcR onenhance the formation of peptide-loaded complexes
macrophages and B cells does not result in efficientwithin the confines of lysosomes (Inaba et al., 2000).
MHC I-restricted presentation. DCs seem to allow theThese complexes then appear in CIIVs, seemingly being
egress of the internalized antigen (3–12 kDa fragments)sorted away from resident lysosomal components includ-
from endocytic organelles into the cytosol (Rodriguezing undegraded HEL (Turley et al., 2000). The CIIVs may
et al., 1999). From here, the fragments enter the “conven-deliver the complexes to the surface (Figure 1, right). This
tional” MHC I pathway involving proteasomal proteoly-pathway of lysosome to plasma membrane vesicle trans-
sis and TAP translocation. Exogenous pathways to MHCport might be a DC-specific specialization, or at least a
class I are especially evident in DCs, but other cells, likepathway that is amplified or synchronously activated in
liver sinusoidal endothelial lining cells and macro-maturing DCs. Moreover, these peptide-MHC complexes
phages, may have this potential. Although little is known
may reach the cell surface as small clusters, partly associ-
about the mechanism of cross-presentation, we suspect
ated with CD86 (Turley et al., 2000). This specialization far more will rapidly emerge concerning the cell biology
may contribute to the efficiency at which DCs display of this pathway and its regulation during DC maturation.
components of the immunological synapse. Antigen Presentation and Tolerance
The entire lysosomal system in DCs appears distin- Transferring what is being learned in vitro to DCs in situ
guished from that in other cells by its ability to attenuate its represents an important challenge. One approach to the
proteolytic potential. Whereas cells such as macrophages problem will involve the use of antigens modified to allow
are adept at rapidly degrading internalized proteins to selective targeting DC-specific surface receptors. One
amino acids, DC lysosomes can sequester antigen for such receptor is the multilectin DEC-205 (Mahnke et al.,
extended periods and still efficiently use the antigen for 2000). In or preliminary results, test antigens such as HEL
forming peptide-MHC class II complexes (Turley et al., were fused to anti-DEC-205 antibodies, injected into mice,
2000). We believe DC lysosomes provide a developmen- and shown to generate DCs with MHC class II-peptide
tally regulated environment adapted for the formation of T complexes capable of eliciting T cell responses in vitro and
cell receptor ligands. How this regulation occurs is unclear, in vivo. Interestingly, the in vivo response was transient,
but may reflect overall alterations in lysosomal enzyme rendering the mice refractory to subsequent injections of
content or lysosomal pH. The immunosuppressive cyto- HEL, even in Freund’s adjuvant. In other words, the animals
kine IL-10 may act in this way to restrict the proteolytic were apparently tolerized to HEL. Tolerance was con-
verted to immunity, however, if the anti-DEC/HEL fusionfunction of monocyte-derived DCs (Fiebiger et al., 2001).
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protein was injected together with a maturation signal, e.g., in tolerizing the T cell repertoire peripherally, and also allows
simultaneous sampling of both the MHC class I and classanti-CD40. Thus, as predicted from the in vitro studies,
immunization requires DC maturation, but tolerance may II systems. MHC restriction therefore remains intact for
other cells and stages of the T cell response.be induced by DCs that have not been induced to mature.
How can this happen if immature cells are incapable of The analysis of DC function in T cell-mediated immu-
nity has always involved three parallel paths of research:forming MHC-peptide complexes?
So-called immature DCs in lymphoid tissues seem to the uptake and presentation of antigens, the cytokines
and surface molecules that control the quality and quan-have one major difference from their in vitro-generated
counterparts: the presence of large amounts of MHC tity of the T cell response, and the properties required to
distribute and mobilize DCs in vivo. We have consideredproducts and MHC-peptide complexes on the surface
of DCs in vivo (Inaba et al., 1998). While this is a feature mechanisms underlying the first topic, stressing the spe-
cializations of these antigen processing machines and theof mature DCs, these cells in vivo otherwise exhibit fea-
tures of immature DCs. Thus, “immature” DCs in importance of DC maturation (Figure 2). A major unknown
remains the endocytic and processing capacities of DCslymphoid organs are endocytically active and express
relatively low levels of key costimulatory molecules like in situ. The cell biology of DCs in vivo will benefit consider-
ably from approaches that involve selective targeting ofCD86 and CD40. The capacity to form MHC-peptide
complexes in the absence of a maturation stimulus and antigens to DCs in situ, as in the DEC-205 work cited
above, imaging studies, selective genetic manipulationin the absence of other changes (costimulatory mole-
of DCs in situ, and continued attention to fundamentalcules, chemokine receptors) that allow mature DCs to
mechanisms defined in culture. Understanding the cellstimulate immunity, may be critical for DCs in situ to be
biological basis for DC function has emerged as an im-able to tolerize T cells in the steady state.
portant and rich area. We suspect it will hold the key toIn constructing a cell type with a broad and efficient
understanding how DCs maintain the balance betweencapacity for antigen presentation (Figure 2), the immune
tolerance for self and immunity against pathogens.system seems to have engaged in a Faustian bargain.
The factors that contribute to the DC’s capacity for im-
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